tiprankstipranks
Trending News
More News >
Innate Pharma SA (FR:IPH)
:IPH

Compare Innate Pharma SA (IPH) vs. Competitors

Compare
10 Followers

Comparison Results

Name
Price
Market Cap
P/E Ratio
Yearly Gain
Analyst Consensus
Analyst Price Target
Top Analysts' Price Target
Smart Score
Follow
Innate Pharma SA
€1.62
€146.55M
-2.82
-17.01%
0 Buy
1 Hold
0 Sell
Hold
Genfit
$6.20
$302.51M
-7.34
64.02%
1 Buy
0 Hold
0 Sell
Moderate Buy
DBV Technologies
€3.05
€602.07M
-3.22
372.14%
1 Buy
0 Hold
0 Sell
Moderate Buy
Nanobiotix
€18.16
€876.76M
455.56%
2 Buy
0 Hold
0 Sell
Moderate Buy
OSE Immunotherapeutics SA
€5.28
€114.40M
-3.26
-32.55%
0 Buy
0 Hold
0 Sell
Moderate Buy
Sensorion SAS
€0.30
€97.69M
-3.05
-54.03%
1 Buy
0 Hold
0 Sell
Moderate Buy

Performance Comparison

Ticker
Company Name
Price
Change
% Change
FR:IPH
Innate Pharma SA
1.55
-0.30
-16.11%
GNFTF
Genfit
6.20
2.51
68.02%
GB:0QAJ
DBV Technologies
3.05
2.41
375.82%
GB:0QAV
Nanobiotix
17.30
14.17
453.42%
DE:6OP
OSE Immunotherapeutics SA
5.16
-1.99
-27.83%
DE:RFM
Sensorion SAS
0.29
-0.34
-54.03%
Compare key indicators and discover each stock’s average analyst price target, as well as the latest recommendations by top Wall Street experts